These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
79 related articles for article (PubMed ID: 232013)
1. Morphometric method for evaluating the neurovirulence of live poliomyelitis vaccine. Tyufanov AV; Stefanov SB Bull World Health Organ; 1979; 57(5):815-7. PubMed ID: 232013 [TBL] [Abstract][Full Text] [Related]
2. Neurovirulence testing of oral poliovaccine in the rhesus monkey. Arya SC Indian J Pathol Microbiol; 1976 Jul; 19(3):185-94. PubMed ID: 186408 [No Abstract] [Full Text] [Related]
3. Neurovirulence test for oral live poliovaccines using poliovirus-sensitive transgenic mice. Abe S; Ota Y; Koike S; Kurata T; Horie H; Nomura T; Hashizume S; Nomoto A Virology; 1995 Feb; 206(2):1075-83. PubMed ID: 7856082 [TBL] [Abstract][Full Text] [Related]
4. Preliminary studies on the neurovirulence of poliomyelitis vaccine (oral) prepared in vero cells. Guo R; Chen SF; Luo GX; Luo QS; Xu QF Proc Chin Acad Med Sci Peking Union Med Coll; 1988; 3(2):104-7. PubMed ID: 2848237 [No Abstract] [Full Text] [Related]
5. [On the neurovirulence test of poliomyelitis-live vaccine. IV. Pathomorphology of monkey poliomyelitis through neuropathogenic poliovirus type 3 (Saukett strain) after intralumbar injection in comparison to the attenuated poliovirus strains]. Unterharnscheidt F; Bonin O; Günther O; Heber L; Schmidt K; Schmidt I; von Mettenheim AE Arch Psychiatr Nervenkr (1970); 1966; 208(1):13-23. PubMed ID: 4290952 [No Abstract] [Full Text] [Related]
6. [Studies on safety tests of inactivated poliomyelitis vaccines. V. Pathomorphological changes in the CNS of rhesus monkeys (Macaca rhesus) and long-tailed monkeys (Cercopithecus aethiops) following intracerebral and intralumbar inoculation with inactivated poliovirus types I, II, and 3]. Unterharnscheidt F; Günther O; Hövel H; Burde K; Heber L Zentralbl Bakteriol Orig; 1966 Jun; 200(2):150-66. PubMed ID: 4296871 [No Abstract] [Full Text] [Related]
7. [On the neurovirulence test of poliomyelitis-live vaccine. V. A statistical method for the evaluation of the experiment for the comparison of neurovirulence in the monkey]. Seinsche D; Bonin O; Unterharnscheidt F; Schmidt K; Schmidt I Arch Psychiatr Nervenkr (1970); 1966; 208(5):433-46. PubMed ID: 4291066 [No Abstract] [Full Text] [Related]
8. [On the neurovirulence test of poliomyelitis-live vaccine. 3. Pathomorphology of monkey poliomyelitis through attenuated polioviruses after intrathalamic infection under particular consideration of differences between virus types]. Unterharnscheidt F; Bonin O; Schmidt K; Schmidt I Arch Psychiatr Nervenkr (1970); 1966; 208(1):1-12. PubMed ID: 4290953 [No Abstract] [Full Text] [Related]
9. [On the neurovirulence test of poliomyelitis-live vaccine. V. A statistical method for the evaluation of the experiment for the comparison of neurovirulence in the monkey]. Seinsche D; Bonin O; Unterharnscheidt F; Schmidt K; Schmidt I Arch Psychiatr Nervenkr (1970); 1966; 208(5):433-46. PubMed ID: 4291332 [No Abstract] [Full Text] [Related]
10. A collaborative study of the histopathological evaluation of the WHO neurovirulence test for poliovirus vaccines. Wood DJ; Heath AB; Marsden SA Biologicals; 1994 Mar; 22(1):45-51. PubMed ID: 8068313 [TBL] [Abstract][Full Text] [Related]
11. Differential susceptibility of transgenic PVR Tg-mice to poliovirus strains with varying neurovirulence in relation with monkeys. Arya SC Biologicals; 1995 Jun; 23(2):191. PubMed ID: 7546663 [No Abstract] [Full Text] [Related]
12. Mutations in Sabin 2 strain of poliovirus and stability of attenuation phenotype. Rezapkin GV; Fan L; Asher DM; Fibi MR; Dragunsky EM; Chumakov KM Virology; 1999 May; 258(1):152-60. PubMed ID: 10329577 [TBL] [Abstract][Full Text] [Related]
13. Transgenic mice as an alternative to monkeys for neurovirulence testing of live oral poliovirus vaccine: validation by a WHO collaborative study. Dragunsky E; Nomura T; Karpinski K; Furesz J; Wood DJ; Pervikov Y; Abe S; Kurata T; Vanloocke O; Karganova G; Taffs R; Heath A; Ivshina A; Levenbook I Bull World Health Organ; 2003; 81(4):251-60. PubMed ID: 12764491 [TBL] [Abstract][Full Text] [Related]
14. Studies on the characteristics of poliovirus type 3. II. Characteristics of "hot" clones. Jarzabek Z; Sadowski W; Kańtoch M; Magrath D; Krawczyński K Acta Virol; 1976 Oct; 20(5):366-72. PubMed ID: 63237 [TBL] [Abstract][Full Text] [Related]
15. [Studies on safety tests of inactivated poliomyelitis vaccines. VI. On the effect of cortisone in monkey experiments]. Günther O; Unterharnscheidt F; Hövel H Zentralbl Bakteriol Orig; 1966 Jun; 200(2):166-79. PubMed ID: 4967641 [No Abstract] [Full Text] [Related]
16. Use of a mathematical model for neurovirulence assay of attenuated poliovirus. Arya SC J Biol Stand; 1977; 5(4):283-7. PubMed ID: 200629 [No Abstract] [Full Text] [Related]
17. Significance of a newly identified attenuating mutation in Sabin 3 oral poliovirus vaccine. Mento SJ; Weeks-Levy C; Tatem JM; Gorgacz EJ; Waterfield WF Dev Biol Stand; 1993; 78():93-9; discussion 99-100. PubMed ID: 8388835 [TBL] [Abstract][Full Text] [Related]
19. Murine neurovirulence studies with a chimeric poliovirus: in vivo generation of a mutant base-paired stable attenuated poliovirus. Lee C; Young C Microb Pathog; 1998 Oct; 25(4):215-25. PubMed ID: 9817825 [TBL] [Abstract][Full Text] [Related]
20. [Prerequisites for neurovirological and neurotoxicological tests in animal experiment]. Glees P Dtsch Med Wochenschr; 1968 Dec; 93(49):2383-6 passim. PubMed ID: 4301399 [No Abstract] [Full Text] [Related] [Next] [New Search]